Free NewsletterPro Login

Warning: Undefined variable $stocks in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 448

Warning: foreach() argument must be of type array|object, null given in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 448

Warning: Undefined variable $funds in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 472

Warning: foreach() argument must be of type array|object, null given in /var/www/briefs.co/htdocs/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 472
/* the link was here */
×
Free investor livestream — Nov 17

How To Use ChatGPT & Claude To Research Stocks Like A Pro

01
The prompt we use to break down any stock
02
How to fact-check what AI tells you
03
How to compare two stocks in minutes

Leo Pharma pushes IPO beyond 2026 as markets stay choppy

Published Nov 16, 2026
Share:
Summary:
  • Leo Pharma has postponed its IPO plans beyond 2026 after previously eyeing a listing this year.
  • CEO Christophe Bourdon said the company has completed the groundwork for an IPO, but choppy markets mean a float won't take place this year, and shareholders will ultimately decide the timetable.
  • Q3 revenue rose 11% at constant exchange rates, and the company reaffirmed its 2026 growth outlook of 9% to 11% on the same basis.

What changed

Leo Pharma, the Danish dermatology-focused drugmaker, is moving its IPO plans out beyond 2026 after previously aiming to list this year. Bourdon noted the firm is prepared for an IPO; however, a listing won't occur this year because market conditions remain unsettled.

"The timing of the IPO lies in the hands of the shareholders and both shareholders have assessed that current market conditions do not support a listing," he said. "An IPO is a natural and viable option for Leo Pharma, and that remains absolutely the case." Bourdon said his work will "continue to focus on what I can control best, which is the performance of the company, delivering in line with our strategic ambition."

The setup behind the delay

Leo Pharma is one of several companies that have postponed listings in recent weeks amid concerns tied to artificial intelligence and rising borrowing costs. A Bloomberg chart showed that expected volatility in the S&P 500 jumped after the US midterm elections. Not everyone is waiting, though. AI lab Anthropic PBC is proceeding toward a very large flotation that may bring in up to $90.4 billion.

Ownership and preparation

Earlier, the owners - Nordic Capital and the Leo Foundation - set their sights on a 2026 IPO, adding that when it happens will hinge on the company's progress and on overall market conditions. Earlier plans from the owners - Nordic Capital and the Leo Foundation - called for a 2026 IPO, with the schedule contingent on the company's execution and the state of the broader market. Leo Pharma has readied itself for years, accelerating once Nordic Capital took a minority stake in 2021 and the company launched a broad restructuring.

Leo Pharma's preparations span years and accelerated once Nordic Capital took a minority stake in 2021, at which point the company embarked on a wide-ranging restructuring. According to Bloomberg, earlier this year the company enlisted seven investment banks to support a potential listing. According to Bloomberg, it brought on seven investment banks earlier this year to prepare for a possible listing.

When companies change course, investors gain by using smarter tools to stay informed. We're hosting our first ever investor livestream on 11/17 to show you how to use ChatGPT and Claude to invest like a pro, hosted by Briefs Finance CEO Jaspreet Singh. Save your seat.

The Leo Foundation owns about 80% of the company. Founded in 1908, Leo Pharma is among Denmark's oldest pharmaceutical firms.

Results and investor takeaways

On Monday, Leo Pharma reported third quarter revenue growth of 11% at constant exchange rates and reaffirmed its 2026 outlook for growth of 9% to 11% by that measure. The bottom line: the company plans to stay private longer while it works toward those targets.

Market timing can be uncertain, and smarter tools can help investors find clarity. On 11/17, our CEO Jaspreet Singh goes live for our first ever investor livestream on how to use ChatGPT and Claude to invest like a pro. Register to join him.

Disclosure

Recent News

1 2 3 … 128

Get Market Briefs delivered to your inbox every morning for free!

No fluff. No noise. No politics. Just finance news you can read in 5 minutes.

Blogs

November 16, 2026
The $40 Trillion National Debt: Trump's 4-Part Plan to Make It Feel Smaller
  • The national debt is above $40 trillion, and the Federal Reserve has gone from sending Washington its profits to losing money.
  • President Trump's four-part plan leans on shorter-term debt, stablecoin companies buying Treasuries, a bigger balance sheet and government stakes in private companies.
  • The goal is to outgrow the debt, not pay it off, so Jaspreet Singh points investors to the seven industries where Washington wants growth.
Read More
November 16, 2026
The Fed Is Talking About a Jumbo Interest Rate Hike. It Has No Easy Way Out
  • The Fed makes its next rate decision on December 9 and is now talking about jumbo interest rate hikes of 0.5%, though one in December looks unlikely.
  • Washington will pay a record $1.05 trillion in interest this year on $40 trillion of debt, and that debt resets at higher rates as the Fed hikes.
  • Jaspreet Singh's five moves are to pay down variable-rate debt, earn interest on your savings, know which stocks feel the pressure, look at value and hedge.
Read More
November 16, 2026
Buying on Margin Is at a Record High. Here's the Risk for the Stock Market
  • Margin debt, the money investors borrow to buy stocks, is at a record of around 4.6% of GDP, up from 3.9% in 2021.
  • ETF money has more than tripled in five years to 7% of GDP, while corporate buybacks and 401(k) money sit below their earlier peaks.
  • Margin calls and panic selling can make the next downturn deeper, so Jaspreet Singh keeps buying broad market funds and says most investors should skip margin debt.
Read More
November 16, 2026
Housing Prices Are Falling. Buying a House Still Isn't Cheaper
  • Housing prices have fallen for four straight weeks, but mortgage rates around 7.2% keep the monthly payment about where it was in 2023.
  • Talk of a jumbo Fed rate hike and a plan to sell Fannie Mae and Freddie Mac on the stock market could both push mortgage rates higher.
  • Briefs Finance CEO Jaspreet Singh treats a house as a liability: buy within your budget and let your investments build the wealth.
Read More
November 14, 2026
Nvidia News: Jensen Huang Is Out, and the "Bank" Behind American AI Just Lost Its Founder
  • Jensen Huang is out at Nvidia over affairs with multiple people, and the company he founded has been the bank of American AI, with about $30 billion into OpenAI and $10 billion into Anthropic.
  • A hotter-than-expected inflation report has Fed officials talking about a possible 0.5% hike in December, and gold, silver, and bitcoin fell on the news.
  • President Trump said the US may not need a deal with Iran, keeping oil prices and inflation risk high. Jaspreet Singh breaks down what it all means for AI stocks and your portfolio.
Read More
November 14, 2026
Record Highs, a 57-Year Low in Jobless Claims, and a Stock Market Bubble: Inside the Weirdest Market in History
  • Stocks are booming at the fastest pace in years, jobless claims just hit a 57-year low, and most investors still feel like nobody is hiring.
  • The Fed is protecting the dollar over the economy, oil swings on every Iran headline, and a few AI companies are carrying an S&P 500 where four of five stocks sit in a correction.
  • Jaspreet Singh explains why circular financing between Nvidia, OpenAI, Anthropic, and SpaceX rhymes with 2008's house of cards, and how his three investing pillars handle a stock market bubble.
Read More
November 14, 2026
Is a Recession Coming? The Fed Just Made a U-Turn It Has Only Made Twice in 60 Years
  • The Fed has raised rates, cut them, then raised them again only twice in the last 60 years, and both times the economy fell into a recession and stocks crashed.
  • The same stop-and-go cycle is playing out now, with one big difference: US debt is 125% of GDP today versus about 30% in 1980.
  • In the 1970s gold rose roughly 24x, real estate 157%, stocks lagged, and cash lost half its value. Jaspreet Singh lays out five assets to consider before the next flip.
Read More
November 14, 2026
The 2027 Tax Brackets Are Out: How Some Investors Can Earn $135,300 and Pay $0
  • The IRS 2027 tax plan keeps the same seven rates but widens every bracket and lifts the married-filing-jointly standard deduction to $33,200.
  • The 0% long-term capital gains bracket rises to $102,100, so a household living on $135,300 of investment income could owe $0 in federal income tax.
  • C corporations still pay 21%, small businesses keep the 20% QBI deduction, and the 401(k) limit climbs to $25,500 with an $8,500 catch-up for investors over 50.
Read More
November 14, 2026
Rare Earth Stocks: Why China's January 2027 Ban Could Be the Opportunity of the Decade
  • China plans to block rare earth exports to the US on January 10, 2027, and the US produces effectively zero of the 17 metals that go into phones, cars, dishwashers, and missiles.
  • When China cut off Japan in 2010 and squeezed Germany from 2015, some rare earth prices jumped 18x and 15x, and one rare earth company went bankrupt while another soared.
  • Washington is already putting billions into MP Materials, Vulcan, and a stockpile called Project Vault, and Jaspreet Singh walks through how investors can get exposure to rare earth stocks and ETFs.
Read More
November 14, 2026
Divided Government Just Changed Where the Money Moves: 5 Market Shifts After the Midterms
  • Democrats took control of Congress, setting up a divided government with a Republican White House, and the biggest spender in the economy is about to change where it spends.
  • The day after the election the market had one of its best days of 2026 while AI stocks, Tesla, and SpaceX fell and clean energy, healthcare, treasuries, gold, and silver rose.
  • Jaspreet Singh maps the five places money is already moving and the history that says stocks rose in the 12 months after each of the last 19 midterms.
Read More
1 2 3 … 33
Share via
Copy link